The evaluation is expected to be completed by him in December European Medicines Agency (EMA) to extend its use BioNTech / Pfizer vaccine for coronavirus (Comirnaty) in children of age 5 to 11 years.
This statement was made earlier today by the head of the EMA for the vaccine strategy, Mark Cavalry. He clarified that for children from 5 to 11 years old, the dose of the vaccine corresponds to 1/3 of the dose approved for adults.
In a press conference he gave, Mr. Cavaleri explained that the European regulatory authority evaluates the benefits and the risks for vaccination of children, referring to data and scientific studies which show that, although to a much lesser extent than adults, children are also can get seriously ill.
It is reminded that The FDA has already given the green light to vaccinate the same age group, with the same formulation, last week, making the Pfizer vaccine the first to be approved in the US for minors aged 5-11.
“Bell” for the epidemic in Europe
Mr Cavaleri also stressed the importance of fully vaccinated all, as well as the number of COVID-19 cases growing again in Europe.
He also noted that most EU Member States have already begun to grant booster doses in people at greater risk of coronavirus infection and transmission and added that extending booster doses to the general population may be the next step.
Regarding the administration of booster doses of the vaccine Janssen, of Johnson & Johnson, 6 months after the 1st dose, Mr. Cavaleri stressed that the data from the clinical trials are expected, as transmitted by ΑΠΕ ΜΠΕ.
Three treatments are going to be approved by the end of 2021
In terms of drug treatments against the coronavirus, the official said that eight treatments are under evaluation by Coreper, five of which are at an advanced stage. At least three treatments are expected to be approved by the end of the year, perhaps before the end of November, he added.
Pregnancy & vaccination
Finally, when asked if the COVID19 vaccine should be recommended on pregnant women, Mr. Cavaleri answered positively, saying that it is clear that pregnant women are also at risk of contracting the disease, while a number of studies show that mRNA vaccines are safe for pregnant women, especially when vaccinated during pregnancy. 2nd and 3rd trimester of pregnancy.
«We fully support and understand the decision of the authorities of the Member States to recommend the vaccination of pregnant women “, said the head of Coreper.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
